Gilead hit with more lawsuits over side effects of AIDS drug.

Michael Weinstein, executive director of AHF, said a large compensation fund would benefit both Gilead and the more than 1,000 patients that are plaintiffs in the multiple lawsuits against Gilead over the TDF issue. (Photo courtesy of AHF)

Another two lawsuits were filed last week in California against the U.S. pharmaceutical company Gilead Sciences, Inc. by several dozen patients who claim the company withheld from the market for more than a decade a drug for treating HIV that…